EazeBio and UC Santa Cruz partner to advance instrument-free diagnostic platform
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Huwel’s diagnostic solutions leverage open RT-PCR system
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
The company previously completed a $150 million venture investment, acquisition, and recapitalization
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
Subscribe To Our Newsletter & Stay Updated